Who is sponsoring NCT04639921?

NCT04639921 is sponsored by Odense University Hospital.

What drugs are being tested in NCT04639921?

Interventions in NCT04639921: positive test followed by gluten-free diet, Placebo.

What condition does NCT04639921 study?

NCT04639921 studies Non-celiac Gluten Sensitivity; Adolescents.

Is NCT04639921 still recruiting?

NCT04639921 is currently status unknown. Last updated 3 March 2021.

Last reviewed 2021-03-03 · How we verify

NCT04639921

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Non Celiac Gluten Sensitivity, DBPCFC in Adolescents

Status unknown NA Last updated 3 March 2021

What this trial tests

NA trial testing positive test followed by gluten-free diet in Non-celiac Gluten Sensitivity; Adolescents in 33 participants. Status unknown.

Timeline

15 October 2020

Primary endpoint
30 May 2021

30 June 2021

Quick facts

Lead sponsor	Odense University Hospital
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	triple
Primary purpose	diagnostic
Enrollment	33
Start date	15 October 2020
Primary completion	30 May 2021
Estimated completion	30 June 2021
Sites	1 location across Denmark

Drugs / interventions tested

positive test followed by gluten-free diet
Placebo

Conditions studied

Non-celiac Gluten Sensitivity; Adolescents — all drugs for Non-celiac Gluten Sensitivity; Adolescents →

Sponsor

Odense University Hospital

Who can join

Adults 15 to 21, any sex, with Non-celiac Gluten Sensitivity; Adolescents. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In a population based on healthy adolescents we will conduct a double blind placebo controlled food challenge (DBPCFC) with cross-over to identify patients with NCGS as recommended by the socalled Salerno criteria. It will take place at Hans Christian Andersen Childrens Hospital at Odense University Hospital, Denmark in October-November 2020.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

The effect of gluten in adolescents and young adults with gastrointestinal symptoms: a blinded randomised cross-over trial.
Crawley C, Savino N, Halby C, Sander SD, et al · · 2022 · cited 13× · PMID 35352373 · DOI 10.1111/apt.16914

Verify or expand the search:

Other Odense University Hospital trials

Trials by the same sponsor.

NCT07163091 — Bracing After Ankle Fracture · NA · not yet recruiting
NCT07521696 — Physical Recovery During Bracing After Ankle Fracture (Re-BAF) · NA · not yet recruiting
NCT07466212 — QoLIDia: Quality of Life in Cancer Patients With Diabetes During Immunotherapy · not yet recruiting
NCT07191379 — Self-administered Subcutaneous Daratumumab in Patients With Multiple Myeloma · Phase 4 · not yet recruiting
NCT07170085 — Positioning of Children With Acute Respiratory Insufficiency · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04639921 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Odense University Hospital
Last refreshed: 3 March 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04639921.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing